Stoxx 600, FTSE, DAX, CAC, Nestle earnings

Nestle Coffee-Mate is sold on a store’s shelves on February 18, 2016 in New York City. Andrew Burton | Getty Images News | Getty Images LONDON — European stocks are expected to open in mixed territory on Thursday as investors await further earnings reports. The U.K.’s FTSE index is seen opening 0.15% higher, Germany’s DAX…

Read More

Stoxx 600, FTSE 100, MSC, defense

European markets traded higher on Monday, as investors digest the key points from this year’s Munich Security Conference. The pan-European Stoxx 600 was up 0.2% at 10:25 a.m. in London (5:25 a.m. ET), with major bourses and most sectors in the region in positive territory. Geopolitics and defense returned to the spotlight as investors focused…

Read More

Nestle 3Q earnings; announces 16,000 job cuts

Jars of Nescafe Instant coffee, part of food giant Nestle’s portfolio, sit on a supermarket shelf in Encinitas, California, U.S., September 2, 2025. Mike Blake | Reuters Nestle said Thursday it will cut 16,000 jobs as the firm’s new CEO Philipp Navratil looks to accelerate a turnaround at the consumer goods giant. In a bid…

Read More

How GLP-1s, Wegovy, Zepbound are reshaping the economy

Eternalcreative | Istock | Getty Images Miracle drugs, obesity treatments and skinny jabs. Call them what you will, few drugs have had a more transformative effect on Wall Street and waistlines over recent decades than GLP-1s. Familiarly known under the brand names Wegovy and Zepbound, Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medication used to…

Read More